The pharmaceutical and healthcare sector is one of the world’s most vital and innovative.
Against a backdrop of technological change and an increasing and aging population, we partner with our clients to help them achieve their goals, capitalise on opportunities and navigate uncertainty.
Combining deep scientific, technical and strategic knowledge we help our clients by providing the commercial nous, experience and range of services that only a large international professional services firm can offer, to anticipate and deliver innovative and value-enhancing solutions.
assisting leading Italian vaccine-developer Achilles Vaccines on various projects, including the creation of a platform for streamlining the research and development of new vaccines (including against COVID-19) and the start of a collaboration with vAMRes Lab at Toscana Life Sciences (TLS) Foundation (based in Siena, Italy) on a research project for the development of human monoclonal antibodies against COVID-19, with the aim of using them for prophylactic/therapeutic purposes and as molecular baits for the discovery of vaccine antigens. We also advised on Italian and German finance, IP and regulatory aspects of its EUR 46 million venture loan financing from EMF EU Malaria Fund (a fund linked to EIB)
Advising Abbvie Inc., on the EU merger control aspects of its US$63 billion acquisition of Allergan
Sterling Pharma Solutions
Advising Sterling Pharma Solutions on its disposal of a UK based pharmaceutical manufacturing business by way of auction sale to GHO Capital
Advising Abcam on its acquisition of Expedeon AG's proteomics and immunology business for €120m
Advising Lupin, on the sale of its entire stake in its Japanese subsidiary, Kyowa Pharmaceutical Industry Co., Ltd. (Kyowa), to Unison Capital for JPY 57.4 billion (c.US$525 million)
Strides Pharma Science Limited
Advising Strides Pharma Science Limited, an Indian listed pharmaceuticals company, on the AU$394 million sale of its entire Australian business, including Arrow Pharmaceuticals, to Arrotex
Insights and updates
Natalie is a Corporate and Mergers & Acquisitions partner with particular expertise in healthcare, aged care and advisory and transactional work for government clients. Natalie is Herbert Smith Freehills’ Sector Lead Partner for Healthcare.